Today: The Maxim Group Reiterates “Buy” Rating for Agenus Inc. (AGEN)

The Maxim Group Reiterates “Buy” Rating for Agenus Inc. (AGEN)

Agenus Inc. (NASDAQ:AGEN)‘s stock had its “buy” rating reissued by Maxim Group in a report released on Thursday. They currently have a $7.00 price objective on the stock. Maxim Group’s target price indicates a potential upside of 71.15% from the stock’s previous close.

A number of other analysts also recently issued reports on AGEN. Zacks Investment Research upgraded Agenus from a “sell” rating to a “hold” rating in a research report on Tuesday, July 5th. Jefferies Group restated a “buy” rating on shares of Agenus in a research report on Tuesday, August 23rd. Finally, HC Wainwright reiterated a “buy” rating and set a $10.00 target price on shares of Agenus in a research report on Sunday, July 31st. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $9.54.

Shares of Agenus (NASDAQ:AGEN) opened at 4.09 on Thursday. The stock’s market capitalization is $355.47 million. Agenus has a 52-week low of $2.61 and a 52-week high of $7.49. The stock has a 50 day moving average of $6.44 and a 200-day moving average of $5.11.

Agenus (NASDAQ:AGEN) last issued its quarterly earnings results on Thursday, October 27th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.29) by $0.18. The company earned $4.45 million during the quarter, compared to the consensus estimate of $6.15 million. Agenus had a negative return on equity of 226.98% and a negative net margin of 472.80%. Analysts predict that Agenus will post ($1.45) EPS for the current fiscal year.

In other news, Director Ulf Wiinberg acquired 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The stock was purchased at an average cost of $6.29 per share, for a total transaction of $188,700.00. Following the completion of the acquisition, the director now directly owns 30,000 shares of the company’s stock, valued at approximately $188,700. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 7.60% of the stock is owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Advisors LLC increased its stake in Agenus by 2.2% in the second quarter. BlackRock Advisors LLC now owns 34,250 shares of the company’s stock valued at $139,000 after buying an additional 722 shares during the last quarter. Fisher Asset Management LLC increased its stake in Agenus by 1.6% in the second quarter. Fisher Asset Management LLC now owns 93,132 shares of the company’s stock valued at $439,000 after buying an additional 1,500 shares during the last quarter. Creative Planning increased its stake in Agenus by 2.8% in the second quarter. Creative Planning now owns 64,171 shares of the company’s stock valued at $260,000 after buying an additional 1,762 shares during the last quarter. Teachers Advisors Inc. increased its stake in Agenus by 6.1% in the second quarter. Teachers Advisors Inc. now owns 117,247 shares of the company’s stock valued at $475,000 after buying an additional 6,742 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Agenus by 2.8% in the second quarter. Bank of New York Mellon Corp now owns 342,133 shares of the company’s stock valued at $1,385,000 after buying an additional 9,403 shares during the last quarter. Hedge funds and other institutional investors own 40.65% of the company’s stock.

Agenus Company Profile

Related posts

Leave a Comment